Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 1, 1993
Importance of sampling both pulmonary veins in grading mitral regurgitation by transesophageal echocardiography
A L Klein, A S Bailey, G I Cohen, et al.
The New England Journal of Medicine
|
November 13, 2018
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J Velazquez, David A Morrow, Adam D DeVore, et al.
ACS Omega
|
January 1, 2025
Machine Learning Prediction of Nitric Acid Extraction Behavior in PUREX Process
Sankar V Harilal, Matilda I Duffy, Eva Brayfindley, et al.
Circulation. Heart Failure
|
February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
David D Berg, Marc D Samsky, Eric J Velazquez, et al.
Journal of Virology
|
July 20, 2001
Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence
K Moeller, I Duffy, P Duprex, et al.
Journal of the American College of Cardiology
|
August 29, 2020
Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists
Andrew P Ambrosy, Eugene Braunwald, David A Morrow, et al.
JAMA Cardiology
|
December 12, 2019
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial
Adam D DeVore, Eugene Braunwald, David A Morrow, et al.
European Heart Journal
|
May 17, 2019
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
David A Morrow, Eric J Velazquez, Adam D DeVore, et al.
ESC Heart Failure
|
November 10, 2020
Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP-HF registry
Yevgeniy Khariton, Gregg C Fonarow, Ann Hellkamp, et al.
Journal of Virology
|
July 10, 1999
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain
W P Duprex, I Duffy, S McQuaid, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 1, 1993
Importance of sampling both pulmonary veins in grading mitral regurgitation by transesophageal echocardiography
A L Klein, A S Bailey, G I Cohen, et al.
The New England Journal of Medicine
|
November 13, 2018
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J Velazquez, David A Morrow, Adam D DeVore, et al.
ACS Omega
|
January 1, 2025
Machine Learning Prediction of Nitric Acid Extraction Behavior in PUREX Process
Sankar V Harilal, Matilda I Duffy, Eva Brayfindley, et al.
Circulation. Heart Failure
|
February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
David D Berg, Marc D Samsky, Eric J Velazquez, et al.
Journal of Virology
|
July 20, 2001
Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence
K Moeller, I Duffy, P Duprex, et al.
Journal of the American College of Cardiology
|
August 29, 2020
Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists
Andrew P Ambrosy, Eugene Braunwald, David A Morrow, et al.
JAMA Cardiology
|
December 12, 2019
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial
Adam D DeVore, Eugene Braunwald, David A Morrow, et al.
European Heart Journal
|
May 17, 2019
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
David A Morrow, Eric J Velazquez, Adam D DeVore, et al.
ESC Heart Failure
|
November 10, 2020
Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP-HF registry
Yevgeniy Khariton, Gregg C Fonarow, Ann Hellkamp, et al.
Journal of Virology
|
July 10, 1999
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain
W P Duprex, I Duffy, S McQuaid, et al.
Page
of 5